Scientists from Sanford Burnham Prebys have created natural-looking hair that grows through the skin using human induced pluripotent stem cells (iPSCs), a major scientific achievement that could revolutionize the hair growth industry.
The findings were presented today at the annual meeting of the International Society for Stem Cell Research (ISSCR) and received a Merit Award. A newly formed company, Stemson Therapeutics, has licensed the technology.
More than 80 million men, women and children in the United States experience hair loss. Genetics, aging, childbirth, cancer treatment, burn injuries and medical disorders such as alopecia can cause the condition. Hair loss is often associated with emotional distress that can reduce quality of life and lead to anxiety and depression.
“Our new protocol described today overcomes key technological challenges that kept our discovery from real-world use,” says Alexey Terskikh, Ph.D., an associate professor in Sanford Burnham Prebys’ Development, Aging and Regeneration Program and the co-founder and chief scientific officer of Stemson Therapeutics. “Now we have a robust, highly controlled method for generating natural-looking hair that grows through the skin using an unlimited source of human iPSC-derived dermal papilla cells. This is a critical breakthrough in the development of cell-based hair-loss therapies and the regenerative medicine field.”
Terskikh studies a type of cell called dermal papilla. Residing inside the hair follicle, these cells control hair growth, including hair thickness, length and growth cycle. In 2015, Terskikh successfully grew hair underneath mouse skin (subcutaneous) by creating dermal papilla derived from human pluripotent stem cells—a tantalizing but uncontrolled process that required further refinement.
The approach detailed in the ISSCR presentation, which was delivered by lead researcher Antonella Pinto, Ph.D., a postdoctoral researcher in the Terskikh lab, features a 3D biodegradable scaffold made from the same material as dissolvable stitches. The scaffold controls the direction of hair growth and helps the stem cells integrate into the skin, a naturally tough barrier. The current protocol relies on mouse epithelial cells combined with human dermal papilla cells. The experiments were conducted in immunodeficient nude mice, which lack body hair.
The derivation of the epithelial part of a hair follicle from human iPSCs is currently underway in the Terskikh lab. Combined human iPSC-derived epithelial and dermal papilla cells will enable the generation of entirely human hair follicles, ready for allogenic transplantation in humans. Distinct from any other approaches to hair follicle regeneration, human iPSCs provide an unlimited supply of cells and can be derived from a simple blood draw.
“Hair loss profoundly affects many people’s lives. A significant part of my practice involves both men and women who are seeking solutions to their hair loss,” says Richard Chaffoo, M.D., F.A.C.S., a triple board-certified plastic surgeon who founded La Jolla Hair MD and is a medical adviser to Stemson Therapeutics. “I am eager to advance this groundbreaking technology, which could improve the lives of millions of people who struggle with hair loss.”
The technology was discovered and developed at Sanford Burnham Prebys. Further development and commercialization activities will be conducted by Stemson Therapeutics. For updates on the technology’s progress and advancement, please visit www.stemsontx.com.
Learn more: Functional hair follicles grown from stem cells
The Latest on: Induced pluripotent stem cells
The Latest on: Biomechanics
via Google News
The Latest on: Induced pluripotent stem cells
- Guiding T lymphopoiesis from pluripotent stem cells by defined transcription factorson November 16, 2019 at 5:25 am
Achievement of immunocompetent and therapeutic T lymphopoiesis from pluripotent stem cells (PSCs) is a central aim in T cell regenerative medicine ... endothelial cell stage and identifying the bona ...
- Heart attack model developed with human stem cellson November 14, 2019 at 3:14 am
Researchers have developed a model of myocardial infarction using cardiomyocytes differentiated from human induced pluripotent stem cells. The study was conducted by researchers at Okayama University ...
- Global Stem Cells Market 2019 by Excellent Revenue Growth by 2025 | MRE Research Reporton November 13, 2019 at 4:31 am
Nov 13, 2019 (Heraldkeepers) -- New York, November 13, 2019: The global stem cells market is expected to grow at an incredible CAGR of 25.5% from 2018 to 2024 and reach a market value of US$ 467 ...
- Induced Pluripotent Stem Cells Market 2019 Global Analysis, Opportunities and Forecast To 2024 | 45 Key Player Profiles Coveredon November 12, 2019 at 3:42 am
Nov 12, 2019 (AB Digital via COMTEX) -- Induced Pluripotent Stem Cells Industry Description According to biology, a pluripotent cell has the ability to differentiate into three of the available germ ...
- Human Stem Cells Help Model Heart Attackon November 9, 2019 at 7:58 am
A model of myocardial infarction (heart attack) using cardiomyocytes differentiated from human induced pluripotent stem cells has been developed by researchers at Okayama University Graduate School of ...
- Human Stem Cells Used to Develop Model of Heart Attackon November 8, 2019 at 5:27 am
Scientists at the Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences report the development of a model of myocardial infarction using cardiomyocytes differentiated ...
- Generation of mouse induced pluripotent stem cells succeeds better without Oct4on November 7, 2019 at 8:32 am
Quality of induced pluripotent stem cells is dramatically enhanced by omitting what was thought to be the most crucial reprogramming factor Scientists at the Max Planck Institute for Molecular ...
- Heart attack modeled with human stem cellson November 7, 2019 at 8:04 am
Researchers at Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences developed a model of myocardial infarction using cardiomyocytes differentiated from human induced ...
- Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogelson October 30, 2019 at 3:18 am
Directed differentiation of induced pluripotent stem cells (iPSCs) towards specific lineages remains a major challenge in regenerative medicine, while there is a growing perception that this process ...
- Synthego Launches High-Throughput Induced Pluripotent Stem Cell Genome Engineeringon October 22, 2019 at 4:06 am
REDWOOD CITY, Calif., Oct. 22, 2019 /PRNewswire/ -- Synthego, the leading genome engineering company, today announced the launch of genome engineering for induced pluripotent stem (iPS) cells. The new ...
via Bing News